ethyl 2-cyanoacrylate has been researched along with Intracranial Arteriovenous Malformations in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, VK; Kanno, T; Katada, K; Katoh, Y; Koga, S; Mashita, S; Sano, H; Takeuchi, A | 1 |
| Adachi, K; Jain, VK; Kanno, T; Katada, K; Kato, Y; Sano, H; Tanji, H | 1 |
2 other study(ies) available for ethyl 2-cyanoacrylate and Intracranial Arteriovenous Malformations
| Article | Year |
|---|---|
Ethyl 2-cyanoacrylate as an embolic agent for cranial arteriovenous malformations. An experimental study.
Topics: Adhesives; Cerebral Angiography; Cyanoacrylates; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformations | 1986 |
The treatment of dural AVM by embolization with aron alpha (ethyl-2-cyanoacrylate).
Topics: Adult; Angiography; Cyanoacrylates; Dura Mater; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Intracranial Arteriovenous Malformations; Male; Middle Aged; Tomography, X-Ray Computed | 1987 |